Q32 Bio Inc.

NasdaqCM:QTTB Stock Report

Market Cap: US$27.0m

Q32 Bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:QTTB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Aug 25SellUS$5,385Shelia VioletteIndividual2,990US$1.80
26 Aug 25SellUS$7,636Lee KalowskiIndividual4,240US$1.80
26 Aug 25SellUS$18,900Jodie MorrisonIndividual10,494US$1.80

Insider Trading Volume

Insider Buying: QTTB insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of QTTB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders113,6560.932%
Public Companies444,3273.64%
Institutions2,155,71317.7%
General Public3,232,66026.5%
VC/PE Firms6,251,25951.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 72.09% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.5%
OrbiMed Advisors LLC
2,252,987US$5.0m0%0.07%
17.1%
Atlas Venture Advisors, Inc.
2,092,106US$4.6m0%0.58%
9.04%
Abingworth LLP
1,102,741US$2.4m0%0.75%
6.59%
Acorn Bioventures
803,425US$1.8m0%0.84%
2.63%
Arch Venture Partners, L.P.
320,482US$708.3k0%0.03%
2.55%
Monaco Asset Management S.A.M.
311,137US$687.6k-47.4%0.25%
2.42%
The Vanguard Group, Inc.
295,409US$652.9k9.64%no data
2.28%
Pfizer Venture Investments LLC
277,777US$613.9k0%0.1%
2%
Sanofi
244,083US$539.4k0%0.03%
1.64%
Bristol-Myers Squibb Company
200,244US$442.5k0%no data
1.1%
Columbia Investment Management Company
133,903US$295.9k0%0.04%
1.07%
Millennium Management LLC
130,379US$288.1k0%no data
0.76%
BlackRock, Inc.
93,005US$205.5k-48%no data
0.73%
Geode Capital Management, LLC
88,496US$195.6k43.7%no data
0.63%
Renaissance Technologies LLC
77,000US$170.2k0%no data
0.55%
Shelia Violette
66,536US$147.0k10.6%no data
0.52%
The Goldman Sachs Group, Inc.
63,539US$140.4k0%no data
0.35%
FMR LLC
42,439US$93.8k-32%no data
0.31%
Jane Street Group, LLC
37,979US$83.9k0%no data
0.24%
Acadian Asset Management LLC
29,739US$65.7k-4.49%no data
0.23%
Affinity Asset Advisors, LLC
27,777US$61.4k0%0.01%
0.22%
State Street Global Advisors, Inc.
26,937US$59.5k-80.4%no data
0.21%
Northern Trust Global Investments
26,058US$57.6k-56.7%no data
0.21%
AQR Capital Management, LLC
26,029US$57.5k-35.6%no data
0.18%
Jodie Morrison
22,506US$49.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/14 09:10
End of Day Share Price 2025/11/14 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Q32 Bio Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas SmithLeerink Partners LLC
Jay OlsonOppenheimer & Co. Inc.
Christopher RaymondPiper Sandler Companies